Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Organo Corporation (6368.T)
Tokyo, JP
Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.62% | -1.98% | +11.16% | +14.42% | +22.25% | +29.12% | +122.81% | +433.54% | +1,034.19% | +3,313.59% | +3,355.53% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Pollution & Treatment Controls: +8.0%+8.8% ★ Q1'26: +4.9% (vs Q1'25)
-
EPS growth Industrial - Pollution & Treatment Controls: +15.8%+17.6% ★ Q1'26: +2.1% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Pollution & Treatment Controls: +35.7%+15.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Industrial - Pollution & Treatment Controls: +10.2%+21.2% ★ Q1'26: +23.1% (vs Q1'25)
-
ROIC Industrial - Pollution & Treatment Controls: +6.6%+19.1% ★ Q1'26: +27.5% (vs Q1'25)
-
Share dilution Industrial - Pollution & Treatment Controls: 0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Pollution & Treatment Controls: -0.39×0.87× Q1'26: 0.71× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 3 EPS Ana. |
Mar 2027 1 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
68.74B
est: 67.59B (+1.7%)
|
79.23B
est: 78.00B (+1.6%)
|
92.27B
est: 84.00B (+9.8%)
|
96.52B
est: 97.50B (-1.0%)
|
100.64B
est: 98.50B (+2.2%)
|
112.07B
est: 112.50B (-0.4%)
|
132.43B
est: 132.98B (-0.4%)
|
150.36B
est: 152.36B (-1.3%)
|
163.27B
est: 167.70B (-2.6%)
|
175.92B
175.65B – 176.05B
+4.9% YoY
|
196.48B
191.27B – 204.03B
+11.7% YoY
|
215.34B
204.10B – 231.63B
+9.6% YoY
|
231.00B
224.88B – 239.87B
+7.3% YoY
|
| EBITDA |
3.42B
est: 10.21B (-66.6%)
|
4.81B
est: 11.79B (-59.2%)
|
7.38B
est: 12.69B (-41.8%)
|
11.02B
est: 14.73B (-25.2%)
|
10.79B
est: 14.88B (-27.5%)
|
12.18B
est: 17.00B (-28.3%)
|
17.04B
est: 20.09B (-15.2%)
|
24.56B
est: 53.64B (-54.2%)
|
33.05B
est: 59.04B (-44.0%)
|
61.93B
61.84B – 61.98B
+4.9% YoY
|
69.17B
67.34B – 71.83B
+11.7% YoY
|
75.81B
71.86B – 81.55B
+9.6% YoY
|
81.32B
79.17B – 84.45B
+7.3% YoY
|
| EBIT |
2.40B
est: 9.36B (-74.4%)
|
3.79B
est: 10.81B (-64.9%)
|
6.46B
est: 11.64B (-44.5%)
|
9.83B
est: 13.51B (-27.2%)
|
9.58B
est: 13.65B (-29.8%)
|
10.85B
est: 15.58B (-30.4%)
|
15.21B
est: 18.42B (-17.4%)
|
22.55B
est: 52.17B (-56.8%)
|
31.12B
est: 57.43B (-45.8%)
|
60.24B
60.15B – 60.29B
+4.9% YoY
|
67.28B
65.50B – 69.86B
+11.7% YoY
|
73.74B
69.89B – 79.32B
+9.6% YoY
|
79.10B
77.00B – 82.14B
+7.3% YoY
|
| Net Income |
1.09B
est: 4.71B (-76.9%)
|
2.78B
est: 2.00B (+39.3%)
|
4.45B
est: 2.35B (+89.8%)
|
7.16B
est: 6.23B (+15.0%)
|
7.07B
est: 5.02B (+40.9%)
|
9.21B
est: 8.58B (+7.4%)
|
11.73B
est: 11.87B (-1.2%)
|
17.31B
est: 18.39B (-5.9%)
|
24.15B
est: 23.08B (+4.6%)
|
28.40B
26.95B – 28.43B
+23.0% YoY
|
31.10B
29.96B – 31.75B
+9.5% YoY
|
33.83B
32.30B – 36.62B
+8.8% YoY
|
38.20B
36.88B – 40.10B
+12.9% YoY
|
| SGA |
11.75B
est: 9.47B (+24.1%)
|
13.58B
est: 10.93B (+24.3%)
|
14.64B
est: 11.77B (+24.4%)
|
15.27B
est: 13.66B (+11.8%)
|
14.45B
est: 13.80B (+4.7%)
|
15.52B
est: 15.76B (-1.6%)
|
17.15B
est: 18.63B (-8.0%)
|
18.47B
est: 20.50B (-9.9%)
|
20.81B
est: 22.56B (-7.8%)
|
23.67B
23.63B – 23.68B
+4.9% YoY
|
26.43B
25.73B – 27.45B
+11.7% YoY
|
28.97B
27.46B – 31.16B
+9.6% YoY
|
31.08B
30.25B – 32.27B
+7.3% YoY
|
| EPS |
23.55
est: 102.36 (-77.0%)
|
60.37
est: 43.43 (+39.0%)
|
97.11
est: 51.05 (+90.2%)
|
156.51
est: 135.51 (+15.5%)
|
154.18
est: 109.25 (+41.1%)
|
200.67
est: 186.61 (+7.5%)
|
255.76
est: 258.22 (-1.0%)
|
376.92
est: 400.29 (-5.8%)
|
525.37
est: 498.24 (+5.4%)
|
601.15
586.15 – 618.40
+20.7% YoY
|
675.43
651.54 – 690.66
+12.4% YoY
|
740.36
702.43 – 796.51
+9.6% YoY
|
830.75
802.13 – 872.24
+12.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fusayoshi Akimoto | Executive Officer | — | — |
| Ken Shimada | Executive Officer | — | — |
| Koh Yoshida | Executive Officer | — | — |
| Koike Shojiro | Managing Executive Officer | — | — |
| Masayuki Yamada | President, Executive Officer & Representative Director | — | male |
| Nobuyoshi Suda | Managing Executive Officer, Head of Technology Development & Director | — | male |
| Shin Asano | Managing Executive Officer | — | — |
| Tetsushi Honda | MD, Executive Officer, President of Corporate Management & Planning and Director | — | male |
| Yasutoshi Nakayama | MD, Managing Exec. Officer, President-Industrial Plant Bus., Sr. GM of Electronics Div. & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6368.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
